11:10 AM EDT, 05/29/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were heading moderately higher late Thursday morning, rising 0.32% to 1,451.76 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies Cellectis ( CLLS ) and Grifols ( GRFS ) , which rose 2.5% and 2.1% respectively. They were followed by pharmaceutical company Ascendis Pharma ( ASND ) , which was up 0.5%.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and biotech firm Evaxion ( EVAX ) , which dropped 8.9% and 6.5% respectively. They were followed by semiconductor company Sequans Communications ( SQNS ) , which dropped 1.6%, accommodations booking company trivago (TRVG), which fell 1.5%, and petroleum refiner Equinor ( EQNR ) , down 0.9%.

From the UK and Ireland, the gainers were led by biotech firms Autolus Therapeutics ( AUTL ) and Trinity Biotech ( TRIB ) , which advanced 7.9% and 5.5% respectively. They were followed by biopharmaceutical companies Bicycle Therapeutics ( BCYC ) and Adaptimmune Therapeutics ( ADAP ) , which increased 4.4% and 1.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana ( NCNA ) and Biodexa Pharmaceuticals ( BDRX ) , which lost 4% and 1.9% respectively. They were followed by education publisher Pearson (PSO) and tobacco company British American Tobacco ( BTI ) , which were both off 0.8%.

Price: 1.45, Change: +0.04, Percent Change: +2.48